BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12413930)

  • 1. Molecular aspects of ovarian cancer.
    Wenham RM; Lancaster JM; Berchuck A
    Best Pract Res Clin Obstet Gynaecol; 2002 Aug; 16(4):483-97. PubMed ID: 12413930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational spectrum of p53 mutations in primary breast and ovarian tumors.
    Feki A; Irminger-Finger I
    Crit Rev Oncol Hematol; 2004 Nov; 52(2):103-16. PubMed ID: 15501075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in the ovary.
    Berchuck A
    J Cell Biochem Suppl; 1995; 23():223-6. PubMed ID: 8747400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular basis of ovarian cancer.
    Gallion HH; Pieretti M; DePriest PD; van Nagell JR
    Cancer; 1995 Nov; 76(10 Suppl):1992-7. PubMed ID: 8634990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2.
    Swisher E
    Curr Womens Health Rep; 2003 Feb; 3(1):27-32. PubMed ID: 12521547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.
    Zweemer RP; Shaw PA; Verheijen RM; Ryan A; Berchuck A; Ponder BA; Risch H; McLaughlin JR; Narod SA; Menko FH; Kenemans P; Jacobs IJ
    J Clin Pathol; 1999 May; 52(5):372-5. PubMed ID: 10560359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
    Aunoble B; Sanches R; Didier E; Bignon YJ
    Int J Oncol; 2000 Mar; 16(3):567-76. PubMed ID: 10675491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary ovarian cancer.
    Prat J; Ribé A; Gallardo A
    Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility testing and prophylactic oophorectomy.
    Berchuck A; Carney ME; Futreal PA
    Eur J Obstet Gynecol Reprod Biol; 1999 Feb; 82(2):159-64. PubMed ID: 10206409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management of women with genomic BRCA1 and BRCA2 mutations.
    Chang J; Elledge RM
    Breast Cancer Res Treat; 2001 Sep; 69(2):101-13. PubMed ID: 11759816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations.
    Casey MJ; Bewtra C
    Fam Cancer; 2004; 3(3-4):265-81. PubMed ID: 15516851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.
    Merajver SD; Pham TM; Caduff RF; Chen M; Poy EL; Cooney KA; Weber BL; Collins FS; Johnston C; Frank TS
    Nat Genet; 1995 Apr; 9(4):439-43. PubMed ID: 7795652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial breast and ovarian cancers.
    Arai M; Utsunomiya J; Miki Y
    Int J Clin Oncol; 2004 Aug; 9(4):270-82. PubMed ID: 15375703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of colorectal cancer.
    Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
    Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human ovarian cancer of the surface epithelium.
    Berchuck A; Carney M
    Biochem Pharmacol; 1997 Sep; 54(5):541-4. PubMed ID: 9337069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
    Rebbeck TR
    J Clin Oncol; 2000 Nov; 18(21 Suppl):100S-3S. PubMed ID: 11060335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
    JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.